2013-2028 Report on Global Biosimilar Drug Market by Player, Region, Type, Application and Sales Channel

Published: Nov, 2019 | Pages: 105 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Biosimilar Drug market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Biosimilar Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biosimilar Drug market.

Leading players of Biosimilar Drug including:
    Amgen
    Eli Lilly
    Novartis
    CP Guojian Pharma
    Biotech Pharma
    ...

Market split by Type, can be divided into:
    Injection
    Tablets
    Other Types

Market split by Application, can be divided into:
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Biosimilar Drug Market Overview
    1.1 Biosimilar Drug Definition
    1.2 Global Biosimilar Drug Market Size Status and Outlook (2013-2028)
    1.3 Global Biosimilar Drug Market Size Comparison by Region (2013-2028)
    1.4 Global Biosimilar Drug Market Size Comparison by Type (2013-2028)
    1.5 Global Biosimilar Drug Market Size Comparison by Application (2013-2028)
    1.6 Global Biosimilar Drug Market Size Comparison by Sales Channel (2013-2028)
    1.7 Biosimilar Drug Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Biosimilar Drug Market Segment Analysis by Player
    2.1 Global Biosimilar Drug Sales and Market Share by Player (2016-2018)
    2.2 Global Biosimilar Drug Revenue and Market Share by Player (2016-2018)
    2.3 Global Biosimilar Drug Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Drug Market Segment Analysis by Type
    3.1 Global Biosimilar Drug Market by Type
        3.1.1 Injection
        3.1.2 Tablets
        3.1.3 Other Types
    3.2 Global Biosimilar Drug Sales and Market Share by Type (2013-2018)
    3.3 Global Biosimilar Drug Revenue and Market Share by Type (2013-2018)
    3.4 Global Biosimilar Drug Average Price by Type (2013-2018)
    3.5 Leading Players of Biosimilar Drug by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Biosimilar Drug Market Segment Analysis by Application
    4.1 Global Biosimilar Drug Market by Application
        4.1.1 Ankylosing Spondylitis
        4.1.2 Tumor
        4.1.3 Rheumatoid Arthrtis
        4.1.4 Cardiovascular
        4.1.5 Other Application
    4.2 Global Biosimilar Drug Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Biosimilar Drug by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Biosimilar Drug Market Segment Analysis by Sales Channel
    5.1 Global Biosimilar Drug Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Biosimilar Drug Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Biosimilar Drug by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Drug Market Segment Analysis by Region
    6.1 Global Biosimilar Drug Market Size and CAGR by Region (2013-2028)
    6.2 Global Biosimilar Drug Sales and Market Share by Region (2013-2018)
    6.3 Global Biosimilar Drug Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Biosimilar Drug Market Share by Type
        6.4.3 North America Biosimilar Drug Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Biosimilar Drug Market Share by Type
        6.5.3 Europe Biosimilar Drug Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Biosimilar Drug Market Share by Type
        6.6.3 Asia-Pacific Biosimilar Drug Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Biosimilar Drug Market Share by Type
        6.7.3 South America Biosimilar Drug Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Biosimilar Drug Market Share by Type
        6.8.3 Middle East & Africa Biosimilar Drug Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Drug Players
    7.1 Amgen
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Eli Lilly
    7.3 Novartis
    7.4 CP Guojian Pharma
    7.5 Biotech Pharma
Chapter 8 Upstream and Downstream Analysis of Biosimilar Drug
    8.1 Industrial Chain of Biosimilar Drug
    8.2 Upstream of Biosimilar Drug
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Biosimilar Drug
        8.3.1 Leading Distributors/Dealers of Biosimilar Drug
        8.3.2 Leading Consumers of Biosimilar Drug
Chapter 9 Development Trend of Biosimilar Drug (2019-2028)
    9.1 Global Biosimilar Drug Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Biosimilar Drug Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Biosimilar Drug Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Biosimilar Drug Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Biosimilar Drug Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Biosimilar Drug Example
    Figure Global Biosimilar Drug Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Biosimilar Drug Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Biosimilar Drug Sales Comparison by Type (2013-2028)
    Figure Global Biosimilar Drug Sales Comparison by Application (2013-2028)
    Figure Global Biosimilar Drug Sales Comparison by Sales Channel (2013-2028)
    Table Global Biosimilar Drug Sales by Player (2016-2018)
    Table Global Biosimilar Drug Sales Market Share by Player (2016-2018)
    Figure Global Biosimilar Drug Sales Market Share by Player in 2018
    Table Global Biosimilar Drug Revenue (Million $) by Player (2016-2018)
    Table Global Biosimilar Drug Revenue Market Share by Player (2016-2018)
    Figure Global Biosimilar Drug Revenue Market Share by Player in 2018
    Table Global Biosimilar Drug Average Price by Player (2016-2018)
    Figure Global Biosimilar Drug Average Price by Player in 2018
    Figure Global Biosimilar Drug Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global Biosimilar Drug Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Injection
    Figure Global Injection Sales and Growth Rate (2013-2018)
    Figure Example of Tablets
    Figure Global Tablets Sales and Growth Rate (2013-2018)
    Figure Example of Other Types
    Figure Global Other Types Sales and Growth Rate (2013-2018)
    Table Global Biosimilar Drug Sales by Type (2013-2018)
    Table Global Biosimilar Drug Sales Market Share by Type (2013-2018)
    Figure Global Biosimilar Drug Sales Market Share by Type in 2018
    Table Global Biosimilar Drug Revenue (Million $) by Type (2013-2018)
    Table Global Biosimilar Drug Revenue Market Share by Type (2013-2018)
    Figure Global Biosimilar Drug Revenue Market Share by Type in 2018
    Table Global Biosimilar Drug Average Price by Type (2013-2018)
    Figure Global Biosimilar Drug Average Price by Type in 2018
    Table Leading Players of Biosimilar Drug by Type in 2018
    Figure Example of Ankylosing Spondylitis
    Figure Global Biosimilar Drug for Ankylosing Spondylitis Sales and Growth Rate (2013-2018)
    Figure Example of Tumor
    Figure Global Biosimilar Drug for Tumor Sales and Growth Rate (2013-2018)
    Figure Example of Rheumatoid Arthrtis
    Figure Global Biosimilar Drug for Rheumatoid Arthrtis Sales and Growth Rate (2013-2018)
    Figure Example of Cardiovascular
    Figure Global Biosimilar Drug for Cardiovascular Sales and Growth Rate (2013-2018)
    Figure Example of Other Application
    Figure Global Biosimilar Drug for Other Application Sales and Growth Rate (2013-2018)
    Table Global Biosimilar Drug Sales by Application (2013-2018)
    Table Global Biosimilar Drug Sales Market Share by Application (2013-2018)
    Figure Global Biosimilar Drug Sales Market Share by Application in 2018
    Table Leading Consumers of Biosimilar Drug by Application in 2018
    Figure Example of Direct Channel
    Figure Global Biosimilar Drug for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Biosimilar Drug for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Biosimilar Drug Sales by Sales Channel (2013-2018)
    Table Global Biosimilar Drug Sales Market Share by Sales Channel (2013-2018)
    Figure Global Biosimilar Drug Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of Biosimilar Drug by Sales Channel in 2018
    Table Global Biosimilar Drug Market Size and CAGR by Region (2013-2028)
    Table Global Biosimilar Drug Sales by Region (2013-2018)
    Table Global Biosimilar Drug Sales Market Share by Region (2013-2018)
    Figure Global Biosimilar Drug Sales Market Share by Region in 2018
    Table Global Biosimilar Drug Revenue (Million $) by Region (2013-2018)
    Table Global Biosimilar Drug Revenue Market Share by Region (2013-2018)
    Figure Global Biosimilar Drug Revenue Market Share by Region in 2018
    Table North America Biosimilar Drug Sales by Country (2013-2018)
    Figure North America Biosimilar Drug Sales Market Share by Country (2013-2018)
    Table North America Biosimilar Drug Revenue by Country (2013-2018)
    Figure North America Biosimilar Drug Revenue Market Share by Country (2013-2018)
    Figure North America Biosimilar Drug Sales Market Share by Type in 2018
    Figure North America Biosimilar Drug Sales Market Share by Application in 2018
    Figure United States Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure United States Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Canada Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Mexico Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Biosimilar Drug Sales by Country (2013-2018)
    Figure Europe Biosimilar Drug Sales Market Share by Country (2013-2018)
    Table Europe Biosimilar Drug Revenue by Country (2013-2018)
    Figure Europe Biosimilar Drug Revenue Market Share by Country (2013-2018)
    Figure Europe Biosimilar Drug Sales Market Share by Type in 2018
    Figure Europe Biosimilar Drug Sales Market Share by Application in 2018
    Figure Germany Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Germany Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure UK Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure France Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Italy Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Russia Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Spain Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Biosimilar Drug Sales by Country (2013-2018)
    Figure Asia-Pacific Biosimilar Drug Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Biosimilar Drug Revenue by Country (2013-2018)
    Figure Asia-Pacific Biosimilar Drug Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Biosimilar Drug Sales Market Share by Type in 2018
    Figure Asia-Pacific Biosimilar Drug Sales Market Share by Application in 2018
    Figure China Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure China Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Japan Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Korea Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure India Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Australia Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Biosimilar Drug Sales by Country (2013-2018)
    Figure South America Biosimilar Drug Sales Market Share by Country (2013-2018)
    Table South America Biosimilar Drug Revenue by Country (2013-2018)
    Figure South America Biosimilar Drug Revenue Market Share by Country (2013-2018)
    Figure South America Biosimilar Drug Sales Market Share by Type in 2018
    Figure South America Biosimilar Drug Sales Market Share by Application in 2018
    Figure Brazil Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Brazil Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Argentina Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Colombia Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Chile Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Biosimilar Drug Sales by Country (2013-2018)
    Figure Middle East & Africa Biosimilar Drug Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Biosimilar Drug Revenue by Country (2013-2018)
    Figure Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Biosimilar Drug Sales Market Share by Type in 2018
    Figure Middle East & Africa Biosimilar Drug Sales Market Share by Application in 2018
    Figure Egypt Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Egypt Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure South Africa Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Biosimilar Drug Sales and Growth Rate (2013-2018)
    Figure Nigeria Biosimilar Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Amgen
    Table Biosimilar Drug Introduction of Amgen
    Table Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share of Amgen (2016-2018)
    Table Industrial Chain of Biosimilar Drug
    Table Manufacturing Cost Structure of Biosimilar Drug
    Table General Manufacturing Process of Biosimilar Drug
    Table Leading Distributors/Dealers of Biosimilar Drug
    Table Leading Consumers of Biosimilar Drug
    Figure Global Biosimilar Drug Sales and Growth Rate Forecast (2019-2028)
    Figure Global Biosimilar Drug Revenue and Growth Rate Forecast (2019-2028)
    Table Global Biosimilar Drug Market Size and CAGR Forecast by Region (2019-2028)
    Table Global Biosimilar Drug Market Size and CAGR Forecast by Type (2019-2028)
    Table Global Biosimilar Drug Market Size and CAGR Forecast by Application (2019-2028)
    Table Global Biosimilar Drug Market Size and CAGR Forecast by Sales Channel (2019-2028)